Investor insights
Sectors invested in
Funding rounds participated in
$1.5M sweet spot round size
Most of their 60 investments are in rounds between $8.2M and $60M
Investor type
Basic info
Industry
Sectors
Date founded
2015
Investments made
Mediar Therapeutics raised $85M on March 15, 2023
Investors: Pureos Bioventures, Gimv, Bristol-Myers Squibb, UK, Sofinnova Partners and Mission BioCapital
QurAlis raised $88M on March 9, 2023
Investors: Sanofi Ventures, Life Sciences Partners (LSP), MP Healthcare Venture Management Inc, Mission Bay Capital, EQT Life Sciences, Inkef and Mission BioCapital
Vaxess Technologies raised $10M on January 10, 2023
Investors: The Engine, RA Capital Management, L.P. and Mission BioCapital
Vaxess Technologies raised $27M on November 2, 2022
Investors: The Engine, Global Health Investment Corporation, RA Capital Management, L.P. and Mission BioCapital
Integrated Biosciences, Inc. raised undisclosed on September 1, 2022
Investors: Root Ventures, Conscience VC, Reinforced Ventures, Polymath Capital Partners and Mission BioCapital
Dren Bio, Inc. raised $65M on June 14, 2022
Investors: HBM Partners AG, Revelation Partners, S.R. One Ltd and Mission BioCapital
ImmunOs Therapeutics AG raised $73M on June 7, 2022
Investors: Gimv, GL Capital Group, PEAK6, Samsara BioCapital, Redalpine, Lightspeed Venture Partners and Mission BioCapital
Nuvig Therapeutics Inc. raised $47M on May 11, 2022
Investors: Digitalis Ventures, Novo Holdings, Bristol-Myers Squibb, UK and Mission BioCapital
Arkuda Therapeutics raised $64M on February 10, 2022
Investors: Surveyor Capital, Atlas Venture, Tekla Capital Management and Mission BioCapital
Ambagon Therapeutics raised $85M on January 6, 2022
Investors: Nextech Invest, RA Capital Management, L.P., Inkef, Surveyor Capital and Mission BioCapital